UBS Group’s Bio Green Med Solution Inc BGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17K | Buy |
2,169
+1,585
| +271% | +$1.75K | ﹤0.01% | 9338 |
|
|
2025
Q4 | $864 | Buy |
584
+544
| +1,360% | +$1.24K | ﹤0.01% | 9786 |
|
|
2025
Q3 | $198 | Sell |
40
-359
| -90% | -$2.77K | ﹤0.01% | 9816 |
|
|
2025
Q2 | $1.98K | Buy |
399
+140
| +54% | +$5.09K | ﹤0.01% | 9538 |
|
|
2025
Q1 | $17.4K | Buy |
259
+62
| +31% | +$5.08K | ﹤0.01% | 8321 |
|
|
2024
Q4 | $17.8K | Buy |
197
+145
| +279% | +$20K | ﹤0.01% | 7955 |
|
|
2024
Q3 | $12.4K | Sell |
52
-106
| -67% | -$34.2K | ﹤0.01% | 7635 |
|
|
2024
Q2 | $61.5K | Buy |
158
+138
| +690% | +$66.3K | ﹤0.01% | 6529 |
|
|
2024
Q1 | $10.2K | Buy |
+20
| New | +$11.8K | ﹤0.01% | 7240 |
|
|
2023
Q3 | – | Hold |
0
| – | -$101 | – | 9541 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8508 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | -$3K | – | 10779 |
|
|
2022
Q3 | $3K | Hold |
1
| – | – | ﹤0.01% | 9520 |
|
|
2022
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 9527 |
|
|
2022
Q1 | $14K | Buy |
+1
| New | +$12.1K | ﹤0.01% | 7926 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9261 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 9621 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | -$24.8K | – | 9438 |
|
|
2021
Q1 | $17K | Buy |
+1
| New | +$28.2K | ﹤0.01% | 7508 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | -$15.3K | – | 8445 |
|
|
2020
Q3 | $11K | Buy |
+1
| New | +$14.9K | ﹤0.01% | 6754 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7994 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7379 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7567 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7157 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7901 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7526 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7539 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 8015 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6934 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7315 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7525 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7138 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7484 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6744 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6859 |
|
|
2016
Q2 | – | Hold |
0
| – | -$1K | – | 7761 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 7420 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7767 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 7804 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7306 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 8089 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 8958 |
|
Other funds holding BGMS
XT
TRCT
SS
AIC
UBS Group's BGMS Position: Q1 2026 in Review
UBS Group increased its Bio Green Med Solution Inc (BGMS) stake by 271% in Q1 2026, buying an estimated $1.75K and bringing the position to 2,169 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #9338.
UBS Group first reported a position in BGMS in Q3 2020 and has held it in 14 quarters since. The position peaked at $61.5K in Q2 2024. 9 funds tracked by Wall St. Rank hold BGMS as of Q1 2026.
- UBS Group held 2,169 shares of Bio Green Med Solution Inc worth $2.17K as of Q1 2026.
- UBS Group bought 1,585 Bio Green Med Solution Inc shares in Q1 2026, an estimated $1.75K.
- Bio Green Med Solution Inc made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9338 holding.
- UBS Group first reported a position in Bio Green Med Solution Inc in Q3 2020 and has held it in 14 quarters since.
- UBS Group's Bio Green Med Solution Inc position peaked at $61.5K in Q2 2024.
- 9 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.